Biomeva Manufacturing specializes in the development and manufacturing of biologics and advanced therapies, offering a comprehensive range of services that include mammalian and microbial production, plasmid DNA, viral vectors, and cell therapy. Their capabilities extend to specialized platforms such as AGCellerate™, BravoAAV™, ProntoLVV™, and Proveo™, which are designed to streamline the development process for various biopharmaceutical products. The company emphasizes its commitment to quality through cGMP manufacturing practices, ensuring compliance with regulatory standards across its global facilities located in key regions including Seattle, Copenhagen, and Heidelberg.

In addition to manufacturing, Biomeva provides extensive support in tech transfer, process development, and analytical formulation development. Their expertise in building stable cell lines and optimizing production processes allows for efficient scaling from pre-clinical stages to full commercialization. The company also focuses on fill and finish services for protein-based drug products and advanced therapies, reinforcing its role as a reliable partner in the biopharmaceutical industry. Through these technologies and services, Biomeva aims to improve patient outcomes by facilitating the timely delivery of innovative therapies to the market.

Germany

Biomeva Manufacturing

Biomeva Manufacturing

Company Details